Variant report

Variant	nsv884052
Chromosome Location	chr6:30059592-30067681
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr6:30063318-30063773	HepG2	liver:	n/a	n/a
2	ATF1	chr6:30065754-30065986	K562	blood:	n/a	n/a
3	BRCA1	chr6:30061983-30062063	HepG2	liver:	n/a	n/a
4	CBX3	chr6:30059166-30060383	HCT-116	colon:	n/a	n/a
5	CHD2	chr6:30059605-30059805	Hela-S3	cervix:	n/a	n/a
6	CTCF	chr6:30065620-30065770	GM06990	blood:	n/a	n/a
7	CTCF	chr6:30062542-30062613	GM10248	blood:	n/a	n/a
8	CTCF	chr6:30063700-30063850	GM12873	blood:	n/a	n/a
9	E2F4	chr6:30067297-30067448	MCF10A-Er-Src	breast:	n/a	n/a
10	E2F6	chr6:30059417-30059818	A549	lung:	n/a	n/a
11	E2F6	chr6:30059270-30059989	H1-hESC	embryonic stem cell:	n/a	n/a
12	E2F6	chr6:30059466-30059872	H1-hESC	embryonic stem cell:	n/a	n/a
13	E2F6	chr6:30059358-30059922	Hela-S3	cervix:	n/a	n/a
14	E2F6	chr6:30059370-30059947	A549	lung:	n/a	n/a
15	ELF1	chr6:30065721-30066093	K562	blood:	n/a	chr6:30065887-30065900
16	EP300	chr6:30063164-30063660	HepG2	liver:	n/a	chr6:30063640-30063650
17	EP300	chr6:30063327-30063508	HepG2	liver:	n/a	n/a
18	EP300	chr6:30063237-30063802	HepG2	liver:	n/a	chr6:30063640-30063650
19	FOS	chr6:30063324-30063521	MCF10A-Er-Src	breast:	n/a	chr6:30063379-30063389 chr6:30063379-30063389 chr6:30063379-30063389
20	FOS	chr6:30059483-30059867	MCF10A-Er-Src	breast:	n/a	chr6:30059510-30059518 chr6:30059506-30059517 chr6:30059508-30059520
21	FOS	chr6:30059408-30059798	MCF10A-Er-Src	breast:	n/a	chr6:30059510-30059518 chr6:30059506-30059517 chr6:30059508-30059520
22	FOS	chr6:30059557-30059824	MCF10A-Er-Src	breast:	n/a	n/a
23	FOS	chr6:30063329-30063521	MCF10A-Er-Src	breast:	n/a	chr6:30063379-30063389 chr6:30063379-30063389 chr6:30063379-30063389
24	FOS	chr6:30059400-30059849	MCF10A-Er-Src	breast:	n/a	chr6:30059510-30059518 chr6:30059506-30059517 chr6:30059508-30059520
25	FOS	chr6:30059368-30059650	HUVEC	blood vessel:	n/a	chr6:30059510-30059518 chr6:30059506-30059517 chr6:30059508-30059520
26	FOS	chr6:30063157-30063610	HUVEC	blood vessel:	n/a	chr6:30063379-30063389 chr6:30063379-30063389 chr6:30063379-30063389
27	FOS	chr6:30063343-30063399	MCF10A-Er-Src	breast:	n/a	chr6:30063379-30063389 chr6:30063379-30063389 chr6:30063379-30063389
28	FOSL2	chr6:30063105-30063881	MCF-7	breast:	n/a	chr6:30063379-30063389 chr6:30063379-30063389 chr6:30063379-30063389
29	FOSL2	chr6:30063034-30063667	A549	lung:	n/a	chr6:30063379-30063389 chr6:30063379-30063389 chr6:30063379-30063389
30	FOSL2	chr6:30063124-30063878	HepG2	liver:	n/a	chr6:30063379-30063389 chr6:30063379-30063389 chr6:30063379-30063389
31	FOSL2	chr6:30059309-30059783	HepG2	liver:	n/a	chr6:30059510-30059518 chr6:30059506-30059517 chr6:30059508-30059520
32	FOSL2	chr6:30063060-30063811	HepG2	liver:	n/a	chr6:30063379-30063389 chr6:30063379-30063389 chr6:30063379-30063389
33	FOSL2	chr6:30063187-30063543	A549	lung:	n/a	chr6:30063379-30063389 chr6:30063379-30063389 chr6:30063379-30063389
34	FOXA1	chr6:30063197-30063792	HepG2	liver:	n/a	chr6:30063506-30063518
35	FOXA1	chr6:30063275-30063610	T-47D	breast:	n/a	chr6:30063506-30063518
36	FOXA1	chr6:30063207-30063850	HepG2	liver:	n/a	chr6:30063506-30063518
37	FOXA1	chr6:30063186-30063810	HepG2	liver:	n/a	chr6:30063506-30063518
38	FOXA1	chr6:30063204-30063831	HepG2	liver:	n/a	chr6:30063506-30063518
39	FOXA2	chr6:30063217-30063777	A549	lung:	n/a	chr6:30063506-30063518
40	FOXA2	chr6:30063281-30063712	HepG2	liver:	n/a	chr6:30063506-30063518
41	FOXA2	chr6:30063130-30063765	A549	lung:	n/a	chr6:30063506-30063518
42	FOXA2	chr6:30062998-30063836	HepG2	liver:	n/a	chr6:30063506-30063518
43	GATA3	chr6:30063094-30063771	MCF-7	breast:	n/a	n/a
44	GTF2F1	chr6:30059465-30059909	Hela-S3	cervix:	n/a	n/a
45	HDAC2	chr6:30063186-30063565	HepG2	liver:	n/a	chr6:30063292-30063306
46	HEY1	chr6:30063197-30063921	HepG2	liver:	n/a	chr6:30063729-30063738
47	HEY1	chr6:30063265-30063681	HepG2	liver:	n/a	n/a
48	HNF4A	chr6:30063241-30063811	HepG2	liver:	n/a	chr6:30063486-30063498 chr6:30063486-30063499 chr6:30063405-30063417 chr6:30063405-30063417
49	HNF4A	chr6:30063166-30063768	HepG2	liver:	n/a	chr6:30063486-30063498 chr6:30063486-30063499 chr6:30063405-30063417 chr6:30063405-30063417
50	HNF4A	chr6:30059338-30059598	HepG2	liver:	n/a	chr6:30059396-30059410 chr6:30059397-30059409 chr6:30059394-30059412 chr6:30059397-30059409

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr6:30067108-30067158	PrEC	prostate:	n/a
2	chr6:30066428-30066478	RPTEC	kidney:	n/a
3	chr6:30067108-30067158	HRPEpiC	eye:	n/a
4	chr6:30067108-30067158	AG09309	skin:	n/a
5	chr6:30066428-30066478	BE2_C	brain:	n/a
6	chr6:30066428-30066478	HRCEpiC	kidney:	n/a
7	chr6:30067108-30067158	NB4	blood:	n/a
8	chr6:30066428-30066478	SKMC	muscle:	n/a
9	chr6:30067108-30067158	NT2-D1	testis:	n/a
10	chr6:30066428-30066478	SK-N-SH	brain:	n/a
11	chr6:30067108-30067158	GM12892	blood:	n/a
12	chr6:30067108-30067158	HPAEpiC	pulmonary alveolar:	n/a
13	chr6:30067108-30067158	PANC-1	pancreas:	n/a
14	chr6:30066428-30066478	NH-A	brain:	n/a
15	chr6:30067108-30067158	GM12891	blood:	n/a
16	chr6:30066428-30066478	LNCaP	prostate:	n/a
17	chr6:30067108-30067158	HRCEpiC	kidney:	n/a
18	chr6:30067108-30067158	SKMC	muscle:	n/a
19	chr6:30066428-30066478	U87	brain:	n/a
20	chr6:30067108-30067158	HEK293	kidney:	embryo
21	chr6:30067108-30067158	PFSK-1	brain:	n/a
22	chr6:30066428-30066478	GM12878	blood:	n/a
23	chr6:30067108-30067158	T-47D	breast:	n/a
24	chr6:30066428-30066478	Jurkat	blood:	n/a
25	chr6:30066428-30066478	HRPEpiC	eye:	n/a
26	chr6:30066428-30066478	HRE	kidney:	n/a
27	chr6:30067108-30067158	CMK	blood:	n/a
28	chr6:30067108-30067158	HRE	kidney:	n/a
29	chr6:30066428-30066478	AoSMC	blood vessel:	n/a
30	chr6:30067108-30067158	U87	brain:	n/a
31	chr6:30067108-30067158	GM12878	blood:	n/a
32	chr6:30067108-30067158	NH-A	brain:	n/a
33	chr6:30066428-30066478	NHBE	bronchial:	n/a
34	chr6:30066428-30066478	PANC-1	pancreas:	n/a
35	chr6:30067108-30067158	AG09319	gingival:	n/a
36	chr6:30067108-30067158	BE2_C	brain:	n/a
37	chr6:30066428-30066478	ovcar-3	ovarian:	n/a
38	chr6:30066428-30066478	Caco-2	colon:	n/a
39	chr6:30067108-30067158	Hela-S3	cervix:	n/a
40	chr6:30066428-30066478	GM19239	blood:	n/a
41	chr6:30067108-30067158	Hepatocyte	liver:	n/a
42	chr6:30066428-30066478	HEEpiC	esophagus:	n/a
43	chr6:30066428-30066478	NT2-D1	testis:	n/a
44	chr6:30067108-30067158	ProgFib	skin:	n/a
45	chr6:30067108-30067158	A549	lung:	n/a
46	chr6:30067108-30067158	SK-N-SH_RA	brain:	n/a
47	chr6:30067108-30067158	GM06990	blood:	n/a
48	chr6:30067108-30067158	MCF-7	breast:	n/a
49	chr6:30066428-30066478	HCM	heart:	n/a
50	chr6:30067108-30067158	MCF10A-Er-Src	breast:	n/a

No.	Distal block	Cell Line	Cell type
1	chr6:30058142..30060356-chr6:30062997..30064640,2	MCF-7	breast:
2	chr6:30059482..30063646-chr6:30064744..30071169,8	MCF-7	breast:
3	chr6:30067592..30070049-chr6:30312859..30314391,2	K562	blood:
4	chr6:30039304..30041261-chr6:30060958..30063803,2	MCF-7	breast:
5	chr6:30036068..30037732-chr6:30063349..30066200,2	MCF-7	breast:
6	chr6:30039673..30045870-chr6:30065915..30071954,9	MCF-7	breast:
7	chr6:30059663..30061808-chr6:30067229..30070058,2	K562	blood:
8	chr6:30043035..30044565-chr6:30066202..30069074,2	MCF-7	breast:
9	chr6:30058142..30060356-chr6:30062997..30064640,2	MCF-7	breast:
10	chr6:30053423..30056076-chr6:30062128..30065252,3	MCF-7	breast:
11	chr6:30054428..30057425-chr6:30058219..30060222,2	MCF-7	breast:
12	chr6:30039555..30048654-chr6:30056865..30065735,15	MCF-7	breast:
13	chr6:30058600..30061539-chr6:30062741..30064895,3	MCF-7	breast:
14	chr6:30027765..30030437-chr6:30060037..30061710,2	MCF-7	breast:
15	chr6:30067195..30070112-chr6:30098151..30100617,2	MCF-7	breast:
16	chr6:30063791..30066840-chr6:30067476..30070156,3	MCF-7	breast:
17	chr6:30027914..30030220-chr6:30065122..30067982,3	MCF-7	breast:
18	chr6:30059663..30061808-chr6:30067229..30070058,2	K562	blood:
19	chr6:30059482..30063646-chr6:30064744..30071169,8	MCF-7	breast:
20	chr6:30039276..30042217-chr6:30067253..30069841,2	K562	blood:
21	chr6:30058600..30061539-chr6:30062741..30064895,3	MCF-7	breast:
22	chr6:30063791..30066840-chr6:30067476..30070156,3	MCF-7	breast:
23	chr6:30033726..30035867-chr6:30063166..30065210,2	MCF-7	breast:
24	chr6:30034665..30036494-chr6:30061234..30063128,2	MCF-7	breast:
25	chr6:30031856..30036259-chr6:30064937..30071315,10	MCF-7	breast:
26	chr6:30041751..30043519-chr6:30060494..30062224,2	K562	blood:
27	chr6:30041901..30046365-chr6:30059553..30065121,9	MCF-7	breast:
28	chr6:30040732..30043488-chr6:30062276..30064354,2	K562	blood:

Variant related genes	Relation type
ENSG00000252901	TF binding region
ENSG00000252901	CpG island
ENSG00000204618	chromatin interactions
ENSG00000204619	chromatin interactions
ENSG00000066379	chromatin interactions
ENSG00000252901	chromatin interactions
ENSG00000204623	chromatin interactions
ENSG00000241370	chromatin interactions

Extended variants
information (count: 331 )
Associated
traits (count: 111 )

Variant overlapped rSNPs/rCNVs (count:331 , 50 per page) page: 1 2 3 4 5 6 7

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs77580993	chr6:30059592-30059593	Enhancers Bivalent Enhancer Strong transcription Flanking Bivalent TSS/Enh Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
2	rs571554851	chr6:30059613-30059614	Enhancers Flanking Active TSS Bivalent Enhancer Strong transcription Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
3	rs78159722	chr6:30059616-30059617	Enhancers Flanking Active TSS Bivalent Enhancer Strong transcription Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
4	rs112053548	chr6:30059642-30059643	Enhancers Flanking Active TSS Bivalent Enhancer Strong transcription Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
5	rs62390183	chr6:30059718-30059719	Enhancers Flanking Active TSS Bivalent Enhancer Strong transcription Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
6	rs145402065	chr6:30059772-30059773	Enhancers Flanking Active TSS Bivalent Enhancer Strong transcription Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
7	rs9261377	chr6:30059819-30059820	Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer Strong transcription Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
8	rs9261378	chr6:30059847-30059848	Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer Strong transcription Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
9	rs531197443	chr6:30059885-30059886	Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer Strong transcription Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
10	rs9261379	chr6:30059888-30059889	Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer Strong transcription Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
11	rs541211853	chr6:30059892-30059893	Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer Strong transcription Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
12	rs564481357	chr6:30059931-30059932	Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer Strong transcription Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
13	rs368792300	chr6:30059937-30059938	Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer Strong transcription Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
14	rs9261380	chr6:30059967-30059968	Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer Strong transcription Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
15	rs532744326	chr6:30059997-30059998	Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer Strong transcription Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
16	rs9261381	chr6:30060002-30060003	Bivalent Enhancer Enhancers Strong transcription Weak transcription Flanking Bivalent TSS/Enh Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
17	rs372062742	chr6:30060016-30060017	Bivalent Enhancer Enhancers Strong transcription Weak transcription Flanking Bivalent TSS/Enh Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
18	rs17187791	chr6:30060021-30060022	Bivalent Enhancer Enhancers Strong transcription Weak transcription Flanking Bivalent TSS/Enh Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
19	rs185459298	chr6:30060035-30060036	Bivalent Enhancer Enhancers Strong transcription Weak transcription Flanking Bivalent TSS/Enh Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
20	rs3132681	chr6:30060041-30060042	Bivalent Enhancer Enhancers Strong transcription Weak transcription Flanking Bivalent TSS/Enh Flanking Active TSS	TF binding region Chromatin interactive region	4 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
21	rs536478358	chr6:30060153-30060154	Bivalent Enhancer Enhancers Strong transcription Weak transcription Flanking Bivalent TSS/Enh Flanking Active TSS	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
22	rs373441370	chr6:30060234-30060235	Weak transcription Bivalent Enhancer Strong transcription Enhancers	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
23	rs2158289	chr6:30060254-30060255	Weak transcription Bivalent Enhancer Strong transcription Enhancers	TF binding region Chromatin interactive region	4 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
24	rs2158288	chr6:30060255-30060256	Weak transcription Bivalent Enhancer Strong transcription Enhancers	TF binding region Chromatin interactive region	4 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
25	rs142500856	chr6:30060259-30060260	Weak transcription Bivalent Enhancer Strong transcription Enhancers	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
26	rs556548985	chr6:30060279-30060280	Weak transcription Bivalent Enhancer Strong transcription Enhancers	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
27	rs571417917	chr6:30060293-30060294	Weak transcription Bivalent Enhancer Strong transcription Enhancers	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
28	rs7749793	chr6:30060364-30060365	Weak transcription Bivalent Enhancer Strong transcription Enhancers	TF binding region Chromatin interactive region	4 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
29	rs60774507	chr6:30060409-30060410	Weak transcription Strong transcription Enhancers	Chromatin interactive region	3 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
30	rs2107201	chr6:30060425-30060426	Weak transcription Strong transcription Enhancers	Chromatin interactive region	3 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
31	rs9261382	chr6:30060472-30060473	Weak transcription Strong transcription Enhancers	Chromatin interactive region	3 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
32	rs376929097	chr6:30060481-30060482	Weak transcription Strong transcription Enhancers	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
33	rs58154054	chr6:30060490-30060491	Weak transcription Strong transcription Enhancers	Chromatin interactive region	3 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
34	rs534933824	chr6:30060498-30060499	Weak transcription Strong transcription Enhancers	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
35	rs557933604	chr6:30060514-30060515	Weak transcription Strong transcription Enhancers	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
36	rs577778398	chr6:30060520-30060521	Weak transcription Strong transcription Enhancers	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
37	rs145312948	chr6:30060532-30060533	Weak transcription Strong transcription Enhancers	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
38	rs386698696	chr6:30060564-30060565	Weak transcription Strong transcription Enhancers	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
39	rs200007453	chr6:30060575-30060576	Weak transcription Strong transcription Enhancers	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
40	rs201192495	chr6:30060578-30060579	Weak transcription Strong transcription Enhancers	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
41	rs202009456	chr6:30060579-30060580	Weak transcription Strong transcription Enhancers	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
42	rs374302280	chr6:30060580-30060581	Weak transcription Strong transcription Enhancers	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
43	rs376081572	chr6:30060582-30060583	Weak transcription Strong transcription Enhancers	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
44	rs201534812	chr6:30060583-30060584	Weak transcription Strong transcription Enhancers	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
45	rs71947786	chr6:30060589-30060590	Weak transcription Strong transcription Enhancers	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
46	rs201392613	chr6:30060596-30060597	Weak transcription Strong transcription Enhancers	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
47	rs28994662	chr6:30060597-30060598	Weak transcription Strong transcription Enhancers	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
48	rs557607036	chr6:30060617-30060618	Weak transcription Strong transcription Enhancers	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
49	rs542201925	chr6:30060619-30060620	Weak transcription Strong transcription Enhancers	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
50	rs7754005	chr6:30060629-30060630	Weak transcription Strong transcription Enhancers	Chromatin interactive region	3 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a

Variant related diseases (count:111)

Disease	PMID	Source
Acute lymphoblastic leukemia	22237106	CNVD
Follicular lymphoma	20505157	CNVD
Glioblastoma multiforme	21080181	CNVD
Ewing''s sarcoma	21437220	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Leukemia	21518781	CNVD
Cancer	21637783	CNVD
Facial dysmorphism	22105932	CNVD
Medulloblastoma	21979893	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Diffuse large b-cell lymphoma	18287131	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	19960244	CNVD
Hepatocellular carcinoma	22174799	CNVD
Endometrial cancer	22040021	CNVD
Acute myeloid leukemia	16864856	CNVD
Breast cancer	21264507	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Cancer	16751803	CNVD
Bladder cancer	19088036	CNVD
Wilms tumour	21544195	CNVD
Uveal melanoma	21693616	CNVD
Biliary cancer	19435499	CNVD
Malaria	21533027	CNVD
Retinoblastoma	19183342	CNVD
Acute myeloid leukemia	20729466	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Prostate cancer	18632612	CNVD
Breast cancer	21858162	CNVD
Lung cancer	18438408	CNVD
Ewing''s sarcoma	17952124	CNVD
Lung cancer	20668451	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Autism	21448237	CNVD
Cancer	20164919	CNVD
Melanoma	18172304	CNVD
Breast cancer	22844521	CNVD
HIV/AIDS	22844521	CNVD
Ovarian cancer	22844521	CNVD
Prostate cancer	22844521	CNVD
Psoriasis	22844521	CNVD
Rheumatoid arthritis	22844521	CNVD
Sclerosis systemic	22844521	CNVD
Systemic lupus erythematosus	22844521	CNVD
Breast cancer	22522925	CNVD
Ovarian cancer	21781307	CNVD
Breast cancer	21552322	CNVD
Immune disease	21076436	CNVD
Autoimmune disease	19135723	CNVD
Systemic lupus erythematosus	17953491	CNVD
Recurrent Infections	22737222	CNVD
Systemic lupus erythematosus	21904924	CNVD
Ependymoma	19289631	CNVD
Gestational infection	22844521	CNVD
Head circumference	22844521	CNVD
Infertility	22844521	CNVD
Recurrent birth weight diabetes	22844521	CNVD
Obesity	22844521	CNVD
Recurrent pregnancy loss	22844521	CNVD
Intellectual disability	21811512	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Congenital anomalies of the kidney and urinary tract	18694510	CNVD
Nasopharyngeal cancer	22815911	CNVD
Hepatocellular carcinoma	16750200	CNVD
Basal cell lymphoma	21115979	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Breast cancer	17133270	CNVD
Autism	22495311	CNVD
Cancer	16790693	CNVD
Cervical cancer	21062161	CNVD
Breast cancer	21785460	CNVD
Retinoblastoma	16790693	CNVD
Esophageal adenocarcinoma	18820669	CNVD
Systemic lupus erythematosus	17503323	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Urothelial carcinoma	18382360	CNVD
Cancer	21183584	CNVD
Hodgkin''s lymphoma	17606441	CNVD
small cell lung cancer	20016488	CNVD
Renal cell carcinoma	18765545	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Gastric cancer	17908304	CNVD
Metanephric adenoma	20802469	CNVD
Splenic marginal zone lymphoma	21957467	CNVD
Schizophrenia	19571809	CNVD
Schizophrenia	19571808	CNVD
Malignant peripheral nerve sheath tumor	18522746	CNVD
Neuroblastoma	16790693	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
abnormal development	18461090	CNVD
Breast cancer	21509527	CNVD
Melanoma	17363583	CNVD
Myelofibrosis	22110671	CNVD
Breast cancer	16397240	CNVD
Retinoblastoma	22278416	CNVD
Non-syndromic sensorineural hearing loss	15273396	CNVD
Systemic lupus erythematosus	20877625	CNVD
Cleidocranial dysplasia	18696259	CNVD
Holoprosencephaly	21359414	CNVD
Liposarcoma	21253554	CNVD
Uveal melanoma	20484589	CNVD
Fibroblasts	20926602	CNVD
Non-syndromic sensorineural hearing loss	17289997	CNVD
Non-syndromic sensorineural hearing loss	17122850	CNVD
Pancreatic cancer	17952125	CNVD

Chromatin state (count:186 , 50 per page) page: 1 2 3 4

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr6:30058400-30059600	Bivalent Enhancer	Fetal Thymus	thymus
2	chr6:30058400-30062200	Strong transcription	Breast Myoepithelial Primary Cells	Breast
3	chr6:30058600-30060400	Enhancers	NHDF-Ad	bronchial
4	chr6:30058600-30061000	Enhancers	Fetal Intestine Small	intestine
5	chr6:30058600-30061400	Enhancers	Fetal Intestine Large	intestine
6	chr6:30058800-30059600	Enhancers	Rectal Mucosa Donor 31	rectum
7	chr6:30058800-30059800	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
8	chr6:30058800-30060200	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
9	chr6:30058800-30060200	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
10	chr6:30058800-30060200	Enhancers	Spleen	Spleen
11	chr6:30059000-30059600	Bivalent Enhancer	Duodenum Mucosa	Duodenum
12	chr6:30059000-30059800	Bivalent Enhancer	Placenta	Placenta
13	chr6:30059000-30059800	Enhancers	Stomach Mucosa	stomach
14	chr6:30059000-30060000	Bivalent Enhancer	IMR90 fetal lung fibroblasts Cell Line	lung
15	chr6:30059000-30060000	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
16	chr6:30059000-30060200	Enhancers	Esophagus	oesophagus
17	chr6:30059000-30060200	Bivalent Enhancer	Fetal Adrenal Gland	Adrenal Gland
18	chr6:30059000-30060200	Enhancers	HSMM	muscle
19	chr6:30059000-30060200	Enhancers	Osteobl	bone
20	chr6:30059000-30060400	Enhancers	Adipose Nuclei	Adipose
21	chr6:30059200-30060200	Enhancers	Muscle Satellite Cultured Cells	--
22	chr6:30059200-30060200	Bivalent Enhancer	Fetal Muscle Trunk	muscle
23	chr6:30059200-30060200	Enhancers	NHEK	skin
24	chr6:30059400-30059600	Enhancers	Foreskin Keratinocyte Primary Cells skin03	Skin
25	chr6:30059400-30059600	Bivalent Enhancer	Colonic Mucosa	Colon
26	chr6:30059400-30059800	Flanking Bivalent TSS/Enh	Foreskin Fibroblast Primary Cells skin02	Skin
27	chr6:30059400-30059800	Enhancers	Foreskin Melanocyte Primary Cells skin03	Skin
28	chr6:30059400-30060000	Enhancers	H1 Cell Line	embryonic stem cell
29	chr6:30059400-30060000	Bivalent Enhancer	H1 Derived Mesenchymal Stem Cells	ES cell derived
30	chr6:30059400-30060000	Enhancers	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
31	chr6:30059400-30060000	Enhancers	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
32	chr6:30059400-30060000	Bivalent Enhancer	Foreskin Fibroblast Primary Cells skin01	Skin
33	chr6:30059400-30060000	Bivalent Enhancer	Fetal Muscle Leg	muscle
34	chr6:30059400-30060000	Enhancers	A549	lung
35	chr6:30059400-30060200	Bivalent Enhancer	HUES6 Cell Line	embryonic stem cell
36	chr6:30059400-30060200	Enhancers	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
37	chr6:30059400-30060200	Enhancers	Foreskin Keratinocyte Primary Cells skin02	Skin
38	chr6:30059400-30060200	Flanking Active TSS	Hela-S3	cervix
39	chr6:30059400-30060200	Flanking Bivalent TSS/Enh	HepG2	liver
40	chr6:30059400-30060200	Enhancers	HMEC	breast
41	chr6:30059400-30060200	Enhancers	HSMMtube	muscle
42	chr6:30059400-30060200	Bivalent Enhancer	NHLF	lung
43	chr6:30059600-30059800	Flanking Active TSS	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
44	chr6:30059600-30059800	Flanking Bivalent TSS/Enh	Duodenum Mucosa	Duodenum
45	chr6:30059600-30059800	Bivalent Enhancer	Skeletal Muscle Female	skeletal muscle
46	chr6:30059600-30060000	Flanking Active TSS	Foreskin Keratinocyte Primary Cells skin03	Skin
47	chr6:30059600-30060000	Flanking Bivalent TSS/Enh	Colonic Mucosa	Colon
48	chr6:30059600-30060000	Enhancers	Gastric	stomach
49	chr6:30059600-30060000	Flanking Active TSS	Rectal Mucosa Donor 31	rectum
50	chr6:30059600-30060000	Bivalent Enhancer	Skeletal Muscle Male	skeletal muscle

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links